CAS 321695-57-2

Formule : C15H15NO5S

InChI : InChI=1S/C15H15NO5S/c1-10-8-12(9-11(2)15(10)17)16-21-22(18,19)14-6-4-13(20-3)5-7-14/h4-9H,1-3H3

Code InChI : VEWFTYOFWIXCIO-UHFFFAOYSA-N

SMILES : CC1=CC(=NOS(=O)(=O)C2=CC=C(C=C2)OC)C=C(C1=O)C

L002

CAS : 321695-57-2

L002

Formule : C₁₅H₁₅NO₅S

Degré de pureté : ≥95%

Masse moléculaire : 321.35

Ref: 54-BUP05707

L002

CAS : 321695-57-2

L002 is a potent inhibitor of acetyltransferase p300 with an IC50 of 1.98 μM, blocking histone and p53 acetylation, and may treat cardiac hypertrophy.

Formule : C₁₅H₁₅NO₅S

Degré de pureté : 98.59%

Couleur et forme : Solid

Masse moléculaire : 321.35

Ref: TM-T11807

4-((((4-Methoxyphenyl)sulfonyl)oxy)imino)-2,6-dimethylcyclohexa-2,5-dien-1-one

CAS : 321695-57-2

Formule : C₁₅H₁₅NO₅S

Degré de pureté : 98%

Couleur et forme : Solid

Masse moléculaire : 321.3483

Ref: IN-DA00CNHE

L002

CAS : 321695-57-2

L002 is a chemical inhibitor that targets lysine acetyltransferases (KATs), which are enzymes responsible for the acetylation of lysine residues on histone and non-histone proteins. This small-molecule inhibitor is derived from a synthetic chemical source utilizing rational design principles to enhance its specificity and efficacy. The mode of action of L002 involves the competitive inhibition of the KATs catalytic activity, which leads to a reduction in protein acetylation levels. This alteration affects chromatin structure and function, thereby influencing gene expression and cellular processes such as proliferation and differentiation.

Formule : C₁₅H₁₅NO₅S

Degré de pureté : Min. 95%

Masse moléculaire : 321.35 g/mol

Ref: 3D-WMA69557